Research output per year
Research output per year
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Association of Circulating Antibody-Secreting Cell Maturity With Disease Features in Primary Sjögren's Syndrome
Steinmetz, T. D., Verstappen, G. M., Schulz, S. R., de Wolff, L., Wilbrink, R., Visser, A., Terpstra, J., Bootsma, H. & Kroese, F. G. M., 19-Dec-2022, (E-pub ahead of print) In: Arthritis and Rheumatology.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Downloads (Pure) -
Change in disease activity is associated with TNF-alpha inhibitor serum levels in patients with axial spondyloarthritis in daily clinical practice
de Wolff, L., Wink, F. R., Bootsma, H., Arends, S. & Spoorenberg, A., 22-Mar-2022, In: Clinical and Experimental Rheumatology. 40, 3, p. 489-494 6 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile8 Downloads (Pure) -
Clinical response to Rituximab is associated with prevention of B-cell driven salivary gland inflammation and epithelial restoration as revealed by molecular pathology: Results from the Tractiss trial in primary Sjogren's Syndrome
Pontarini, E., Chowdhury, F., Sciacca, E., Grigoriadou, S., Murray-Brown, W., Rivellese, F., Lucchesi, D., Goldmann, K., Fossati-Jimack, L., Jaworska, E., Ghirardi, G. M., Nerviani, A., Emery, P., Ng, W. F., Sutcliffe, N., Tappuni, A., Lewis, M., Arends, S., De Wolff, L., Bootsma, H., & 3 others, 23-May-2022, In: Annals of the Rheumatic Diseases. 81, p. 299-300 2 p.Research output: Contribution to journal › Meeting Abstract › Academic
-
Evaluation of cress in the phase 2 randomised placebo-controlled study of sequential belimumab/rituximab administration in patients with primary Sjögren’s syndrome
Bootsma, H., Arends, S., de Wolff, L., Clark, K. L., van Maurik, A., Mistry, P., Shukla, P., Nihtyanova, S., Fox, N. L. & Roth, D., Jun-2022, In: Annals of the Rheumatic Diseases. 81, p. 329-330 2 p.Research output: Contribution to journal › Meeting Abstract › Academic
-
Immunisation with Coronavirus-2 vaccines induces potent antibody responses and does not aggravate the lymphocyte compartment of primary Sjögren’s syndrome patients
Steinmetz, T. D., de Wolff, L., Terpstra, J. H., Visser, A., Bootsma, H., Kroese, F. G. M. & Verstappen, G. M., 20-Dec-2022, In: Clinical and Experimental Rheumatology. 40, 12, p. 2338-2343 6 p.Research output: Contribution to journal › Article › Academic › peer-review
Activities
- 2 Professional or public presentation
-
Ontwikkeling van een samengesteld eindpunt voor geneesmiddelenonderzoek in Sjögren patiënten
Suzanne Arends (Speaker) & Liseth de Wolff (Speaker)
1-Oct-2022Activity: Talk and presentation › Professional or public presentation › Popular
-
Composite of Relevant Endpoints for Sjögren’s Syndrome (CRESS) – external validation
Suzanne Arends (Speaker) & Liseth de Wolff (Speaker)
21-Jan-2021Activity: Talk and presentation › Professional or public presentation › Professional
Prizes
-
Sjögren Award 2022
Arends, Suzanne (Recipient) & de Wolff, Liseth (Recipient), 1-Oct-2022
Prize › Academic